PCV52 PRESCRIBING AND EXPENDITURES FOR PCSK9 INHIBITORS IN THE MEDICARE PART D POPULATION IN 2016

May 1, 2019, 00:00 AM
10.1016/j.jval.2019.04.488
https://www.valueinhealthjournal.com/article/S1098-3015(19)30680-1/fulltext
Section Title :
Section Order : 10128
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)30680-1&doi=10.1016/j.jval.2019.04.488
HEOR Topics :
Tags :
Regions :